. Author manuscript; available in PMC: 2010 Nov 1.

Published in final edited form as: Cancer Treat Rev. 2009 Aug 5;35(7):597–607. doi: 10.1016/j.ctrv.2009.07.001

Table 2.

The new or ongoing clinical trials to investigate the value of I3C or DIM in cancer clinic ^*.

NCT ID	Title
NCT00607932	Brassica vegetables or indole-3-carbinol in treating patients with PSA recurrence after surgery for prostate cancer
NCT00450229	Diindolylmethane in treating patients undergoing surgery for stage I or stage II prostate cancer
NCT00305747	Diindolylmethane in treating patients with nonmetastatic prostate cancer that has not responded to previous hormone therapy
NCT00462813	Diindolylmethane in treating patients with abnormal cervical cells
NCT00212381	Oral diindolylmethane (DIM) for the treatment of cervical dysplasia
NCT00784394	Diindolylmethane in healthy nonsmokers

Information collected from ClinicalTrials.gov